Pharma shares witnessed buying demand for second consecutive trading session. At 14:25 IST, the barometer index, the S&P BSE Sensex surged 569.20 points or 0.67% to 85,498.66. The Nifty 50 index added ...

The rally is buoyed on escalating tensions in Venezuela and expectations for more US rate cuts. Silver and platinum have also ...

Wockhardt shares surged 5 percent to trade at Rs 1,446.70 apiece, emerging as the top gainer on the Nifty Pharma index. Laurus Labs climbed nearly 3 percent, while Divi’s Laboratories advanced around ...

The sharp rise in the share prices pushed the Nifty Pharma index up 0.65 percent to 22,704.30, as seen at 11.15 am on Friday. Earlier during the day, the index gained more than 1.35 percent to 22,863.

Bao Pharmaceuticals Co. Ltd., a developer of subcutaneous biologic drugs, priced its IPO at HK$26.38 on Dec. 2, aiming to raise about HK$1 billion (US$128 million). Bao expects net proceeds of ...

Shriram Finance, Tata Steel, Hindalco Industries, M&M, Bajaj Auto were among major gainers on the Nifty, while losers included Max Healthcare, Eternal, Apollo Hospitals, Interglobe Aviation, Tata ...

Behind the scenes activity in the US IPO market is reaching a fever pitch, according to dealmakers, as companies lured by stock markets near record highs prepare to go public. The industry has been ...

After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine ...

The startup’s filing comes during a broader biotech recovery that’s made some industry watchers optimistic IPOs could rebound ...

The U.S. IPO market roared back in 2025, as the 176 initial public offerings during the first half of the year matched the full-year total for 2024. IPO activity remained strong during Q3 with 65 ...

The year 2025 started off red hot for startups going public, and then things got complicated. Market froth, tariffs, and the longest government shutdown on record combined to throw cold water on the ...